SEC Scores Early Win In Mass. Biotech CEO Fraud Suit

By Reenat Sinay · December 6, 2019, 2:40 PM EST

A Massachusetts federal judge has awarded the U.S. Securities and Exchange Commission an early victory in its suit against two biotech companies and former CEO Patrick Muraca over his misappropriation of investor...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

United States Securities and Exchange Commission v. Muraca et al

Case Number

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

July 31, 2017

Recent Articles By Reenat

March 08, 2021
Ex-Med Tech Exec Cops To Obstructing Feds' Purdue Probe
February 16, 2021
Accused PPP Fraudster Says Vaccine Hurdles Could Bias Jury
February 12, 2021
Grifters Offered Moderna Vaccine On Copycat Site, Feds Say
January 25, 2021
'Pharma Bro' Shkreli Can't Have FTC Prison Call Transcripts
January 11, 2021
Justices Nix 2nd Circ. Insider Trading Ruling After Bridgegate
December 18, 2020
Biotech CEO Charged With Pushing Fake Fast COVID-19 Test
December 07, 2020
Feds Ask 1st Circ. To Reinstate Full Insys Kickback Verdict
November 12, 2020
Researcher Cops To Hiding China Ties To Win $4M In Grants
October 13, 2020
Theranos Founder Elizabeth Holmes Can't Shake New Charges
October 02, 2020
Feds Charge 3 In Alleged $109M Medicare Fraud Scheme